False-positive mammograms may indicate increased risk for breast cancer later in life
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after…
Oncology
Experimental drug may stop cancer-induced cachexia
Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health, according to…
The essence of nursing, in our readers’ words
Promoting health and easing suffering—these goals lie at the heart of the essence of nursing. Given the many demands of nursing—call lights, phone calls,…
How to evaluate qualitative research
Editor’s note: This article is a follow-up to “Understanding qualitative research,” published in the July issue of American Nurse Today. Have you ever told…
Guidelines for patients with thyroid conditions
The American Thyroid Association has released guidelines for managing adult patients with thyroid nodules and differentiated thyroid cancer. Access the guidelines.
Some thoughts on addiction
I recently wrote a posting related to nurses caring for patients with addictions in response to a Facebook posting exchange. Below is the exchange,…
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer whose disease…
Managing delirium in hospitalized older adults
Lawrence Jeffries, age 78, is admitted to the hospital for an arthroplasty of the left hip. A retired roofer, he lives with his wife…
From our readers: One patient’s story
Eric’s* storytelling made a difference in my nursing practice. Eric was a 27-year-old African American patient with end-stage renal disease (ESRD), who was admitted…
FDA approves new drugs
·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with…
False-positive mammograms may indicate increased risk for breast cancer later in life
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10…
Experimental drug may stop cancer-induced cachexia
Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health,…
The essence of nursing, in our readers’ words
Promoting health and easing suffering—these goals lie at the heart of the essence of nursing. Given the many demands of nursing—call lights,…
How to evaluate qualitative research
Editor’s note: This article is a follow-up to “Understanding qualitative research,” published in the July issue of American Nurse Today. Have you…
Guidelines for patients with thyroid conditions
The American Thyroid Association has released guidelines for managing adult patients with thyroid nodules and differentiated thyroid cancer. Access the guidelines.
Some thoughts on addiction
I recently wrote a posting related to nurses caring for patients with addictions in response to a Facebook posting exchange. Below is…
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer…
Managing delirium in hospitalized older adults
Lawrence Jeffries, age 78, is admitted to the hospital for an arthroplasty of the left hip. A retired roofer, he lives with…
From our readers: One patient’s story
Eric’s* storytelling made a difference in my nursing practice. Eric was a 27-year-old African American patient with end-stage renal disease (ESRD), who…
FDA approves new drugs
·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.